- Home
- BCTX vs COSM Comparison
BCTX vs COSM Comparison
Compare BCTX & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCTX
- COSM
- Stock Information
- Founded
- BCTX 2014
- COSM 2009
- Country
- BCTX Canada
- COSM United States
- Employees
- BCTX N/A
- COSM N/A
- Industry
- BCTX Biotechnology: Pharmaceutical Preparations
- COSM Other Pharmaceuticals
- Sector
- BCTX Health Care
- COSM Health Care
- Exchange
- BCTX Nasdaq
- COSM Nasdaq
- Market Cap
- BCTX 13.7M
- COSM 12.3M
- IPO Year
- BCTX N/A
- COSM 2013
- Fundamental
- Price
- BCTX $0.69
- COSM $0.78
- Analyst Decision
- BCTX Strong Buy
- COSM
- Analyst Count
- BCTX 1
- COSM 0
- Target Price
- BCTX $32.00
- COSM N/A
- AVG Volume (30 Days)
- BCTX 2.1M
- COSM 1.4M
- Earning Date
- BCTX 06-16-2025
- COSM 08-18-2025
- Dividend Yield
- BCTX N/A
- COSM N/A
- EPS Growth
- BCTX N/A
- COSM N/A
- EPS
- BCTX N/A
- COSM N/A
- Revenue
- BCTX N/A
- COSM $53,554,457.00
- Revenue This Year
- BCTX N/A
- COSM $28.14
- Revenue Next Year
- BCTX N/A
- COSM N/A
- P/E Ratio
- BCTX N/A
- COSM N/A
- Revenue Growth
- BCTX N/A
- COSM N/A
- 52 Week Low
- BCTX $0.61
- COSM $0.28
- 52 Week High
- BCTX $29.40
- COSM $1.58
- Technical
- Relative Strength Index (RSI)
- BCTX 21.33
- COSM 53.77
- Support Level
- BCTX $0.61
- COSM $0.75
- Resistance Level
- BCTX $0.78
- COSM $1.28
- Average True Range (ATR)
- BCTX 0.05
- COSM 0.17
- MACD
- BCTX 0.07
- COSM 0.01
- Stochastic Oscillator
- BCTX 34.43
- COSM 37.90
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.